Respective ef- fects of early cerebral and abdominal magnetic resonance imaging on clinical decisions in infective endocarditis. Eur Heart J Cardiovasc Imaging. 499. Meshaal MS, Kassem HH, Samir A, Zakaria A, Baghdady Y, Rizk HH. Impact of routine cerebral CT angiography on treatment deci- sions in infective endocarditis. PLoS One. 2015;10:e0118616. doi: 500. Stortecky S, Franzone A, Heg D, Tueller D, Noble S, Pilgrim T, Jeger R, Toggweiler S, Ferrari E, Nietlispach F, et al. Temporal trends in adoption and outcomes of transcatheter aortic valve implantation: a SwissTAVI Registry analysis. Eur Heart J Qual Care Clin Outcomes. 2019;5:242 251. doi: 501. Guerrero M, Vemulapalli S, Xiang Q, Wang DD, Eleid M, Cabalka AK, Sandhu G, Salinger M, Russell H, Greenbaum A, et al. Thirty-day out- comes of transcatheter mitral valve replacement for degenerated mi- tral bioprostheses (valve-in-valve), failed surgical rings (valve-in-ring), and native valve with severe mitral annular calcification (valve-in-mitral annular calcification) in the United States: data from the Society of Thoracic Surgeons/American College of Cardiology/Transcatheter Valve Therapy Registry. Circ Cardiovasc Interv. 2020;13:e008425. doi: 502. Dangas GD, Tijssen JGP, W hrle J, S ndergaard L, Gilard M, M llmann H, Makkar RR, Herrmann HC, Giustino G, Baldus S, et al; GALILEO Investigators. A controlled trial of rivaroxaban after transcatheter aortic-valve replacement. N Engl J Med. 2020;382:120 129. doi: 503. De Backer O, Dangas GD, Jilaihawi H, Leipsic JA, Terkelsen CJ, Makkar R, KiniAS,VeienKT,Abdel-WahabM,KimWK,etal;GALILEO-4DInvestigators. Reduced leaflet motion after transcatheter aortic-valve replacement. N Engl J Med. 2020;382:130 139. doi: 10.1056/NEJMoa1911426 504. P ss J, Desch S, Eitel C, de Waha S, Thiele H, Eitel I. Left ventricular throm- bus formation after ST-segment-elevation myocardial infarction: insights from a cardiac magnetic resonance multicenter study. Circ Cardiovasc 505. 